These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5300 related articles for article (PubMed ID: 6221609)

  • 21. [Platelet aggregation and endogenous prostaglandins and thromboxane (author's transl)].
    Katori M
    No Shinkei Geka; 1980 Aug; 8(8):717-22. PubMed ID: 6999371
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of prostaglandins, prostacyclin, and thromboxanes in the control of prenatal patency and postnatal closure of the ductus arteriosus.
    Coceani F; Olley PM
    Semin Perinatol; 1980 Apr; 4(2):109-13. PubMed ID: 6990501
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of prostaglandins, prostacyclin, and thromboxanes in the control of the umbilical-placental circulation.
    Tuvemo T
    Semin Perinatol; 1980 Apr; 4(2):91-5. PubMed ID: 6990507
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
    Ambrus JL; Ambrus CM; Gastpar H; Williams P
    J Med; 1982; 13(1-2):35-47. PubMed ID: 6288824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysosomal cathepsin B: correlation with metastatic potential.
    Sloane BF; Dunn JR; Honn KV
    Science; 1981 Jun; 212(4499):1151-3. PubMed ID: 7233209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible strategies for antimetastastic therapy.
    Honn KV; Onoda JM; Menter DG; Cavanaugh PG; Taylor JD; Crissman JD; Ryan RE; Sloane BF
    Prog Clin Biol Res; 1986; 212():217-49. PubMed ID: 3520578
    [No Abstract]   [Full Text] [Related]  

  • 27. Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575).
    Honn KV; Meyer J; Neagos G; Henderson T; Westley C; Ratanatharathorn V
    Prog Clin Biol Res; 1982; 89():295-331. PubMed ID: 7051034
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
    Ambrus JL; Ambrus CM; Gastpar H
    Prog Clin Biol Res; 1982; 89():83-95. PubMed ID: 7111311
    [No Abstract]   [Full Text] [Related]  

  • 29. Animal models for the study of platelet-tumor cell interactions.
    Donati MB; Rotillio D; Delaini F; Giavazzi R; Mantovani A; Poggi A
    Prog Clin Biol Res; 1982; 89():159-76. PubMed ID: 7202205
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological interactions between prostacyclin and thromboxanes.
    Whittle BJ; Moncada S
    Br Med Bull; 1983 Jul; 39(3):232-8. PubMed ID: 6313114
    [No Abstract]   [Full Text] [Related]  

  • 31. [Recent progress in prostaglandin research. Biochemistry of thromboxanes, prostacyclin, and leukotrienes (author's transl)].
    Murota S
    Seikagaku; 1982 Jan; 54(1):1-23. PubMed ID: 7042856
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical significance of prostaglandins and other arachidonic acid metabolites. Prostacyclin (PGI2), thromboxane A2, leukotriene].
    Oelz O
    Ther Umsch; 1982 Oct; 39(10):751-8. PubMed ID: 6760444
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study.
    Menter DG; Harkins C; Onoda J; Riorden W; Sloane BF; Taylor JD; Honn KV
    Invasion Metastasis; 1987; 7(2):109-28. PubMed ID: 3294727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic interaction of prostaglandins, thromboxane, and prostacyclin: potential nonreproductive veterinary clinical applications.
    Bell TG; Smith WL; Oxender WD; Maciejko JJ
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1195-200. PubMed ID: 6260722
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostacyclin: its biosynthesis, actions and clinical potential.
    Moncada S; Vane JR
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):305-29. PubMed ID: 6117893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the vascular responses to various prostanoic compounds in the puppy and adult dog.
    Fitzpatrick T; Harris R; Ramwell P; Kot P
    Adv Prostaglandin Thromboxane Res; 1980; 7():727-9. PubMed ID: 6989200
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prostacyclins and thromboxanes, new substances from the prostanoid group].
    Masek K; Kadlec O
    Cas Lek Cesk; 1980 Jul; 119(29-30):785-7. PubMed ID: 7000358
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibition of metastasis by anti-platelet agents-prostaglandins].
    Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1228-34. PubMed ID: 3890759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biochemistry and significance of prostaglandins, prostacyclins, thromboxanes and leukotrienes and the modification of their biosynthesis by essential fatty acids].
    Kolb E
    Z Gesamte Inn Med; 1985 Mar; 40(6):165-72. PubMed ID: 2988221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 265.